The Scientific and Medical Team at IGM Biosciences is responsible for advancing the company's proprietary IgM antibody technology platform. This team, composed of experts in clinical development, strategy, scientific research, and medical oversight, leads the design and execution of clinical studies, oversees the progression of product candidates through early and late-stage clinical trials, and develops strategic initiatives for autoimmune, inflammation, and infectious disease applications. They also ensure rigorous scientific research and medical compliance throughout the product development lifecycle, aiming to innovate and improve therapeutic outcomes.
View all